Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H26N4O5S |
Molecular Weight | 470.541 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)C1=C(C)N=C(N2CCC(CC2)C(=O)NS(=O)(=O)CC3=CC=CC=C3)C(=C1)C#N
InChI
InChIKey=NEMHKCNXXRQYRF-UHFFFAOYSA-N
InChI=1S/C23H26N4O5S/c1-3-32-23(29)20-13-19(14-24)21(25-16(20)2)27-11-9-18(10-12-27)22(28)26-33(30,31)15-17-7-5-4-6-8-17/h4-8,13,18H,3,9-12,15H2,1-2H3,(H,26,28)
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q9H244 Gene ID: 64805.0 Gene Symbol: P2RY12 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/23899349 |
31.5 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptor. | 2013 Nov |
|
Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor. separation of the antithrombotic effect and bleeding for candidate drug AZD1283. | 2013 Sep 12 |
|
Structure of the human P2Y12 receptor in complex with an antithrombotic drug. | 2014 May 1 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
KDT372MQ8M
Created by
admin on Sat Dec 16 19:10:33 GMT 2023 , Edited by admin on Sat Dec 16 19:10:33 GMT 2023
|
PRIMARY | |||
|
23649325
Created by
admin on Sat Dec 16 19:10:33 GMT 2023 , Edited by admin on Sat Dec 16 19:10:33 GMT 2023
|
PRIMARY | |||
|
919351-41-0
Created by
admin on Sat Dec 16 19:10:33 GMT 2023 , Edited by admin on Sat Dec 16 19:10:33 GMT 2023
|
PRIMARY |
ACTIVE MOIETY